Related Experiment Videos
Acute low back pain with radiculopathy: a double-blind, randomized, placebo-controlled study
Ljubica M Konstantinovic1, Zeljko M Kanjuh, Andjela N Milovanovic
1Clinic for Rehabilitation, Medical School, Belgrade, Serbia. ljkonstantinovic@yahoo.com
Photomedicine and Laser Surgery
|December 17, 2009
Summary
Low-level laser therapy (LLLT) significantly improves outcomes for acute low back pain (LBP) with radiculopathy when used alongside medication. This treatment demonstrated superior results compared to medication alone or medication with placebo laser therapy.
Area of Science:
- Orthopedics and Rehabilitation
- Pain Management
- Physical Therapy Modalities
Background:
- Acute low back pain (LBP) with radiculopathy presents significant pain and disability.
- Inflammation plays a key pathogenic role in LBP with radiculopathy.
- Low-level laser therapy (LLLT) exhibits notable anti-inflammatory effects.
Purpose of the Study:
- To evaluate the clinical efficacy of LLLT as an adjunct treatment for acute LBP with radiculopathy.
- To compare the effects of LLLT combined with medication versus medication alone.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involving 546 patients.
- Three groups: nimesulide + active LLLT, nimesulide alone, and nimesulide + placebo LLLT.
- LLLT parameters: 904 nm wavelength, 5000 Hz frequency, 100 mW power, 20 mW/cm² power density, 3 J/cm² dose per treatment.
Main Results:
- All measured outcomes (pain intensity, lumbar movement, disability, quality of life) showed statistically significant improvements (p < 0.001).
- Group A (nimesulide + active LLLT) demonstrated significantly greater improvements than Group B (nimesulide alone) and Group C (nimesulide + placebo LLLT) (p < 0.0005).
- Group C showed better results than Group B (p < 0.0005).
Conclusions:
- LLLT as an additional therapy offers superior improvement for acute LBP with radiculopathy.
- The combination of LLLT and nimesulide is more effective than nimesulide alone or with placebo LLLT.